Zoetis Inc. (BIT:1ZTS)

Market Cap	64.83B
Revenue (ttm)	8.59B
Net Income (ttm)	2.33B
Shares Out	n/a
EPS (ttm)	5.15
PE Ratio	27.83
Forward PE	25.65
Dividend	1.72 (1.24%)
Ex-Dividend Date	Apr 18, 2025

Volume	3
Average Volume	35
Open	141.24
Previous Close	135.42
Day's Range	138.82 - 141.24
52-Week Range	125.98 - 185.04
Beta	n/a
RSI	61.42
Earnings Date	May 6, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ZTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD